The eligibility of primary tumor resection for de novo stage IV breast cancer patients

Tadahiko Shien

doi:10.21037/tcr.2018.05.28

The eligibility of primary tumor resection for de novo stage IV breast cancer patients

Tadahiko Shien

University Hospital

Research output: Contribution to journal › Editorial › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	S604-S607
Journal	Translational Cancer Research
Volume	7
DOIs	https://doi.org/10.21037/tcr.2018.05.28
Publication status	Published - 2018

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/tcr.2018.05.28

Cite this

@article{fc8bd007dd48419cb7048af8a40bc004,

title = "The eligibility of primary tumor resection for de novo stage IV breast cancer patients",

author = "Tadahiko Shien",

note = "Funding Information: Funding: This report was supported in part by the National Funding Information: This report was supported in part by the National Cancer Center Research and Development Fund (29-A-3) from the Ministry of Health, Labour and Welfare and the Practical Research for Innovative Cancer Control (18ck0106307h0002) from Japan Agency for Medical Research and Development, AMED",

year = "2018",

doi = "10.21037/tcr.2018.05.28",

language = "English",

volume = "7",

pages = "S604--S607",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - The eligibility of primary tumor resection for de novo stage IV breast cancer patients

AU - Shien, Tadahiko

N1 - Funding Information: Funding: This report was supported in part by the National Funding Information: This report was supported in part by the National Cancer Center Research and Development Fund (29-A-3) from the Ministry of Health, Labour and Welfare and the Practical Research for Innovative Cancer Control (18ck0106307h0002) from Japan Agency for Medical Research and Development, AMED

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85048216330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048216330&partnerID=8YFLogxK

U2 - 10.21037/tcr.2018.05.28

DO - 10.21037/tcr.2018.05.28

M3 - Editorial

AN - SCOPUS:85048216330

SN - 2218-676X

VL - 7

SP - S604-S607

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -

The eligibility of primary tumor resection for de novo stage IV breast cancer patients

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this